Kronans Droghandel, AB
IFS extends collaboration with pharmaceuticals distributor
Published in Lab Business Week, June 13th, 2004
Both companies have signed an operating agreement valued at nearly $2 million for IFS. IFS will help KD operate, upgrade, and support IFS applications during the 5-year term of the agreement.
One aim of the agreement is to make it easier for KD to collaborate more closely with its customers and suppliers by providing them with access to parts of KD's business applications. Licenses have been extended to enable this.
Under the terms of the agreement, IFS and KD will prioritize the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2004-06-13)
More Articles from Lab Business Week
- Aerogen, Inc.
Respiratory disease drug firm's stockholders approve closing of $32.7M financing - Amarin Corporation plc
Neuroscience company reports on restructuring, financials - AmeriPath, Inc.
Cancer diagnostics company reports financials after merger - American Oriental Bioengineering
Double-digit revenue, income growth expected by Chinese biotech firm - Amicus Therapeutics, Inc.
Drug development company raises $31M in series B financing - AmpliMed Corp.
Chemotherapy developer completes extended series A financing - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
